.jpg)
Nolan Townsend
CEO,
Lexeo Therapeutics
R. Nolan Townsend currently serves as Lexeo Therapeutics Chief Executive Officer and member of the Board of Directors. Prior to Lexeo, Mr. Townsend held multiple roles at Pfizer including President, Pfizer Rare Disease for the North America region and President, Pfizer Rare Disease for the International markets; overseeing overall strategy and the cross functional organization and operating budget in those regions. Prior to Pfizer, Mr. Townsend worked in the healthcare investment banking group at Lehman Brothers, advising healthcare companies on strategic financing transactions and mergers and acquisitions.
Mr. Townsend serves on the Board of Directors of Arbor Biotechnologies, the Biotechnology Innovation Organization (BIO), and Life Science Cares New York in addition to an appointment to New York City Economic Development Corporation’s Life Sciences Advisory Council.
Mr. Townsend received his Masters in Business Administration from the Harvard Business School and his Bachelor of Arts in Economics from the University of Pennsylvania.
Suffix
MBA
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}